PROJECT

Projects

Environmental & Social Review Summary

Project Number

25947

Company Name

GRANULES INDIA LIMITED

Date ESRS Disclosed

May 3, 2007

Country

India

Region

South Asia

Last Updated Date

Jun 3, 2021

Environmental Category

B - Limited

Status

Completed

Previous Events

Approved : Jun 7, 2007
Signed : Jun 8, 2007
Invested : Jun 14, 2007

Sector

Pharmaceuticals and Medicine

Industry

Health, Education and Life Sciences

Department

Gbl Ind, Manufact, Agribus & Services

Project Description

Granules India Limited (Granules or the company) is a medium-sized generic pharmaceutical company based in Hyderabad, State of Andhra Pradesh, India. It is a leading manufacturer of pharmaceutical formulation intermediates (PFIs). PFIs are blends of single or multiple active pharmaceutical ingredients (APIs) and excipients, ready to be compressed into tablets or filled into capsules. Granules also manufactures and sells APIs and formulations in over 35 countries globally. The company focuses mainly on a portfolio of high-volume drugs that have experienced post patent price erosions in the past (e.g. ibuprofen, paracetamol, aspirin, etc.). Granules has grown from one plant (Bonthapally) in 1987 to three (a new facility at the Bonthapally site plus plants at Gagilapur, and Jeedimetla, constructed in 2003 and 2006 respectively). A fourth plant is currently under construction at the 20-acre Gagilapur campus for the production of tablets; it is expected to be operational by June 2007. The company’s expansion plan is to leverage on its strength in low cost, large volume manufacturing and move up the industry value chain by expanding its product basket to include 8-10 new products each year, and manufacturing select, higher margin prescription drugs for the US and EU markets. To do so, Granules is in the process of setting up a new API and formulations facility and related product developments and registrations.

Overview of IFC's Scope of Review

This is a Category B project according to IFC’s Procedure for Environmental and Social Review of Projects because a limited number of specific environmental and social impacts may result which can be avoided or mitigated by adhering to generally recognized performance standards, guidelines or design criteria. The following potential environment, health and safety and social aspect of the project were analyzed:

- social and environmental assessment and environmental, social, and health and safety management systems;
- labor and working conditions;
- pollution prevention and abatement;
- community health, safety and security; and
- land acquisition and involuntary resettlement.

The review of this project consisted of appraising technical, environmental and social information submitted by the project sponsor including detailed questionnaires on the environmental and health and safety aspects of each of its facilities, including independent Environmental Impact Assessment (EIA) reports prepared for both the Bonthapally and the Jeedimetla Industrial Development Areas (IDAs). During project appraisal IFC visited all three of Granules’ production facilities (Bonthapally, Jeedimetla and Gagilapur) in the Hyderabad area, and held discussions interacted with Granules senior management team regarding the company’s Human Resource policies and procedures.

E & S Project Categorization and Applicable Standard

Environmental and Social Mitigation Measures

Stakeholder Engagement

Client Documentation

File Name Actions
ESAP_25947.pdf